SHIN SUNG TK CO LIMITED is planning to invest approximately 40 million and more in different phases in India.
SHIN SUNG TK CO LIMITED of South Korea in a Joint Venture with Père-d-biz Consulting has entered the healthcare segment in India under MAKE IN INDIA program of Prime Minister Narendra Modi. It is planning to invest approximately 40 million and more in different phases in India, as per the requirement and going to generate a large number of the employment across India in R&D, Sales & Marketing, Pre-sales & post-sales support and Software Development area.
EUN-SUAB LIM, President of SHIN SUNG, said, “The product iRINGER is a result of very intense R&D done in the Research and Development Institute of SHIN SUNG in South Korea. There were many countries running after taking this opportunity to manufacture iRINGER in their respective countries, but with the help of Indian Embassy in Republic of Korea, INDIA INVEST and KOREA PLUS team a Joint Venture agreement was signed between SHIN SUNG TK Co LTD and Père-d-biz Consulting on 1 st April 2019, to manufacture the product in India to address the indigenous and global demand.”
iRINGER will report and manage the setup of the speed of drops as prescribed by the doctor and specific to the medicine used for IV. In particular, iRINGER provides alarm through smart call (automatic call) in case of abnormality and receives a favourable response from hospital nurses.